Outlook Therapeutics launches $100M stock offering, discloses cash down to $7.7M

Filed May 13, 2026 · Period ending May 12, 2026 · ~1 min read

Key Changes

• high

  Company entered new at-the-market offering to sell up to $100M of common stock through H.C. Wainwright, replacing prior BTIG program. Shares will be sold directly into market at prevailing prices, diluting existing holders.

  Item 1.01 verify on EDGAR →
• high

  Preliminary cash position was just $7.7M as of March 31, 2026, excluding $4.5M raised in April offering. Total available liquidity approximately $12.2M suggests urgent need for additional capital.

  Item 8.01 view on EDGAR →
• medium

  Terminated existing $100M ATM agreement with BTIG (dated May 2023) effective May 12, 2026, and immediately replaced it with new H.C. Wainwright program on same terms.

  Item 1.02 verify on EDGAR →